{
  "abstract": "Central diabetes insipidus (CDI) is an uncommon condition characterized by deficient vasopressin secretion, resulting in polyuria, polydipsia, and the potential for dehydration and electrolyte disturbances. Desmopressin, a synthetic form of vasopressin, remains the cornerstone of treatment. Desmoda, an oral liquid formulation of desmopressin approved by the United States Food and Drug Administration, provides a novel, ready-to-use option appropriate for all age demographics, especially infants and individuals with dysphagia. It facilitates accurate, weight-based dosing without requiring tablet handling or refrigeration. Desmoda signifies significant progress in CDI care; however, caution is warranted regarding hyponatremia and its use in patients with renal impairment.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Anesthesia and Critical Care, All India Institute of Medical Science, Rishikesh, Uttarakhand, India.",
    "Department of Trauma and Emergency, All India Institute of Medical Science, Jodhpur, Rajasthan, India.",
    "Department of Anesthesia and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India.",
    "Department of Pediatrics, All India Institute of Medical Science, Jodhpur, Rajasthan, India."
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Konica Chittoria"
    },
    {
      "affs": [
        1
      ],
      "name": "Ankur Sharma"
    },
    {
      "affs": [
        2
      ],
      "name": "Arun Mukesh"
    },
    {
      "affs": [
        3
      ],
      "name": "Varuna Vyas"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7tbmvvdh5yt4c.bib",
  "cited_by": 0,
  "doi": "10.4103/sja.sja_509_26",
  "fulltext_url": "https://europepmc.org/articles/PMC13719100",
  "id": "7tbmvvdh5yt4c",
  "issns": [
    "1658-354X",
    "0975-3125"
  ],
  "landing_url": "https://europepmc.org/article/MED/42960364",
  "language": "eng",
  "licence": "CC-BY-NC-SA",
  "licence_label": "CC BY-NC-SA",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Review Article"
    ],
    [
      "openalex",
      "2740|Electrolyte and hormonal disorders"
    ]
  ],
  "openalex": "W7215066691",
  "pdf_url": "https://europepmc.org/articles/PMC13719100?pdf=render",
  "pmcid": "PMC13719100",
  "pmid": "42960364",
  "published": "2026-10-01",
  "publisher": "Wolters Kluwer -- Medknow Publications",
  "ris": "https://research.draconitic.com/paper/7tbmvvdh5yt4c.ris",
  "sources": [
    {
      "first_seen": "2026-11-01T00:20:52Z",
      "native_id": "MED:42960364",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42960364"
    },
    {
      "first_seen": "2026-11-02T12:23:00Z",
      "native_id": "PMC13719100",
      "source": "pmc",
      "url": "https://doi.org/10.4103/sja.sja_509_26"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2740|Electrolyte and hormonal disorders",
      "subfield": "general"
    }
  ],
  "title": "Desmoda: The latest US FDA-approved oral desmopressin solution for all age groups.",
  "title_text": "Desmoda: The latest US FDA-approved oral desmopressin solution for all age groups.",
  "type": "peer-reviewed",
  "updated_at": "2026-11-02T12:23:00Z",
  "url": "https://research.draconitic.com/paper/7tbmvvdh5yt4c",
  "venue": "Saudi journal of anaesthesia",
  "versions": []
}